Mildronate (Meldonium) in professional sports – monitoring doping control urine samples using hydrophilic interaction liquid chromatography – high resolution/high accuracy mass spectrometry

Abstract

To date, substances such as Mildronate (Meldonium) are not on the radar of anti‐doping laboratories as the compound is not explicitly classified as prohibited. However, the anti‐ischemic drug Mildronate demonstrates an increase in endurance performance of athletes, improved rehabilitation after exercise, protection against stress, and enhanced activations of central nervous system (CNS) functions.In the present study, the existing evidence of Mildronate's usage in sport, which is arguably not (exclusively) based on medicinal reasons, is corroborated by unequivocal analytical data allowing the estimation of the prevalence and extent of misuse in professional sports. Such data are vital to support decision‐making processes, particularly regarding the ban on drugs in sport. Due to the growing body of evidence (black market products and athlete statements) concerning its misuse in sport, adequate test methods for the reliable identification of Mildronate are required, especially since the substance has been added to the 2015 World Anti‐Doping Agency (WADA) monitoring program.In the present study, two approaches were established using an in‐house synthesized labelled internal standard (Mildronate‐D3). One aimed at the implementation of the analyte into routine doping control screening methods to enable its monitoring at the lowest possible additional workload for the laboratory, and another that is appropriate for the peculiar specifics of the analyte, allowing the unequivocal confirmation of findings using hydrophilic interaction liquid chromatography‐high resolution/high accuracy mass spectrometry (HILIC‐HRMS). Here, according to applicable regulations in sports drug testing, a full qualitative validation was conducted. The assay demonstrated good specificity, robustness (rRT=0.3%), precision (intra‐day: 7.0–8.4%; inter‐day: 9.9–12.9%), excellent linearity (R>0.99) and an adequate lower limit of detection (<10 ng/mL). © 2015 The Authors. Drug Testing and Analysis published by John Wiley & Sons, Ltd.

False Negative Results in Testing for Drugs of Abuse from Diluted Urine

“… Some laboratories, in particular in area of doping controls, concentrated (spiked) urine samples or special normalization procedures that are based on specific gravity and creatinine content within the measured urine are recommended for accurate urine drug testing programs [24,25].…”

Annual banned‐substance review: analytical approaches in human sports drug testing

“…Facts and evidence of use in 2015 (when the drug was not prohibited but on WADA's monitoring program) were provided by Stuart et al . as well as Goergens et al . A total of 8.7% of the doping control urine samples collected at the European Games held in Baku 2015 were found to contain meldonium and 8320 random sports drug testing samples measured in 2015 in Germany returned 2.2% of findings for the drug.…”

Pharmacokinetics and pharmacodynamics of meldonium in exercised thoroughbred horses

“…Although developed as a therapeutic medication, meldonium has found widespread use in human sports, so much so that the World Anti‐Doping Agency (WADA) has, over the last several years, instituted procedures to monitor the use and potential abuse of the drug . Findings from this monitoring demonstrated a substantial prevalence of meldonium in human doping control samples.…”